Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Brand Drugs market report explains the definition, types, applications, major countries, and major players of the Brand Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Merck & Co (MSD)
Sanofi
Allergan
Pfizer
Gilead Sciences
Eli Lilly
Johnson & Johnson
Novartis
Bristol-Myers Squibb
Shire
Novo Nordisk
AbbVie
Roche
Boehringer Ingelheim
Teva
AstraZeneca
Bayer
Amgen
Takeda
GlaxoSmithKline (GSK)
By Type:
Biopharmaceutical
Chemistry Medicine
By End-User:
Hospital
Clinic
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Brand Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Brand Drugs Outlook to 2028- Original Forecasts
-
2.2 Brand Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Brand Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Brand Drugs Market- Recent Developments
-
6.1 Brand Drugs Market News and Developments
-
6.2 Brand Drugs Market Deals Landscape
7 Brand Drugs Raw Materials and Cost Structure Analysis
-
7.1 Brand Drugs Key Raw Materials
-
7.2 Brand Drugs Price Trend of Key Raw Materials
-
7.3 Brand Drugs Key Suppliers of Raw Materials
-
7.4 Brand Drugs Market Concentration Rate of Raw Materials
-
7.5 Brand Drugs Cost Structure Analysis
-
7.5.1 Brand Drugs Raw Materials Analysis
-
7.5.2 Brand Drugs Labor Cost Analysis
-
7.5.3 Brand Drugs Manufacturing Expenses Analysis
8 Global Brand Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Brand Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Brand Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Brand Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Brand Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemistry Medicine Consumption and Growth Rate (2017-2022)
-
9.2 Global Brand Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Brand Drugs Market Analysis and Outlook till 2022
-
10.1 Global Brand Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Brand Drugs Consumption (2017-2022)
-
10.2.2 Canada Brand Drugs Consumption (2017-2022)
-
10.2.3 Mexico Brand Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Brand Drugs Consumption (2017-2022)
-
10.3.2 UK Brand Drugs Consumption (2017-2022)
-
10.3.3 Spain Brand Drugs Consumption (2017-2022)
-
10.3.4 Belgium Brand Drugs Consumption (2017-2022)
-
10.3.5 France Brand Drugs Consumption (2017-2022)
-
10.3.6 Italy Brand Drugs Consumption (2017-2022)
-
10.3.7 Denmark Brand Drugs Consumption (2017-2022)
-
10.3.8 Finland Brand Drugs Consumption (2017-2022)
-
10.3.9 Norway Brand Drugs Consumption (2017-2022)
-
10.3.10 Sweden Brand Drugs Consumption (2017-2022)
-
10.3.11 Poland Brand Drugs Consumption (2017-2022)
-
10.3.12 Russia Brand Drugs Consumption (2017-2022)
-
10.3.13 Turkey Brand Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Brand Drugs Consumption (2017-2022)
-
10.4.2 Japan Brand Drugs Consumption (2017-2022)
-
10.4.3 India Brand Drugs Consumption (2017-2022)
-
10.4.4 South Korea Brand Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Brand Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Brand Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Brand Drugs Consumption (2017-2022)
-
10.4.8 Thailand Brand Drugs Consumption (2017-2022)
-
10.4.9 Singapore Brand Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Brand Drugs Consumption (2017-2022)
-
10.4.11 Philippines Brand Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Brand Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Brand Drugs Consumption (2017-2022)
-
10.5.2 Colombia Brand Drugs Consumption (2017-2022)
-
10.5.3 Chile Brand Drugs Consumption (2017-2022)
-
10.5.4 Argentina Brand Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Brand Drugs Consumption (2017-2022)
-
10.5.6 Peru Brand Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Brand Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Brand Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Brand Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Brand Drugs Consumption (2017-2022)
-
10.6.3 Oman Brand Drugs Consumption (2017-2022)
-
10.6.4 Qatar Brand Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Brand Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Brand Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Brand Drugs Consumption (2017-2022)
-
10.7.2 South Africa Brand Drugs Consumption (2017-2022)
-
10.7.3 Egypt Brand Drugs Consumption (2017-2022)
-
10.7.4 Algeria Brand Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Brand Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Brand Drugs Consumption (2017-2022)
11 Global Brand Drugs Competitive Analysis
-
11.1 Merck & Co (MSD)
-
11.1.1 Merck & Co (MSD) Company Details
-
11.1.2 Merck & Co (MSD) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Merck & Co (MSD) Brand Drugs Main Business and Markets Served
-
11.1.4 Merck & Co (MSD) Brand Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sanofi
-
11.2.1 Sanofi Company Details
-
11.2.2 Sanofi Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sanofi Brand Drugs Main Business and Markets Served
-
11.2.4 Sanofi Brand Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Allergan
-
11.3.1 Allergan Company Details
-
11.3.2 Allergan Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Allergan Brand Drugs Main Business and Markets Served
-
11.3.4 Allergan Brand Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Brand Drugs Main Business and Markets Served
-
11.4.4 Pfizer Brand Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Gilead Sciences
-
11.5.1 Gilead Sciences Company Details
-
11.5.2 Gilead Sciences Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Gilead Sciences Brand Drugs Main Business and Markets Served
-
11.5.4 Gilead Sciences Brand Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Eli Lilly
-
11.6.1 Eli Lilly Company Details
-
11.6.2 Eli Lilly Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Eli Lilly Brand Drugs Main Business and Markets Served
-
11.6.4 Eli Lilly Brand Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Johnson & Johnson
-
11.7.1 Johnson & Johnson Company Details
-
11.7.2 Johnson & Johnson Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Johnson & Johnson Brand Drugs Main Business and Markets Served
-
11.7.4 Johnson & Johnson Brand Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Novartis
-
11.8.1 Novartis Company Details
-
11.8.2 Novartis Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Novartis Brand Drugs Main Business and Markets Served
-
11.8.4 Novartis Brand Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bristol-Myers Squibb
-
11.9.1 Bristol-Myers Squibb Company Details
-
11.9.2 Bristol-Myers Squibb Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bristol-Myers Squibb Brand Drugs Main Business and Markets Served
-
11.9.4 Bristol-Myers Squibb Brand Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Shire
-
11.10.1 Shire Company Details
-
11.10.2 Shire Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Shire Brand Drugs Main Business and Markets Served
-
11.10.4 Shire Brand Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novo Nordisk
-
11.11.1 Novo Nordisk Company Details
-
11.11.2 Novo Nordisk Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novo Nordisk Brand Drugs Main Business and Markets Served
-
11.11.4 Novo Nordisk Brand Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 AbbVie
-
11.12.1 AbbVie Company Details
-
11.12.2 AbbVie Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 AbbVie Brand Drugs Main Business and Markets Served
-
11.12.4 AbbVie Brand Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Roche
-
11.13.1 Roche Company Details
-
11.13.2 Roche Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Roche Brand Drugs Main Business and Markets Served
-
11.13.4 Roche Brand Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Boehringer Ingelheim
-
11.14.1 Boehringer Ingelheim Company Details
-
11.14.2 Boehringer Ingelheim Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Boehringer Ingelheim Brand Drugs Main Business and Markets Served
-
11.14.4 Boehringer Ingelheim Brand Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Teva
-
11.15.1 Teva Company Details
-
11.15.2 Teva Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Teva Brand Drugs Main Business and Markets Served
-
11.15.4 Teva Brand Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 AstraZeneca
-
11.16.1 AstraZeneca Company Details
-
11.16.2 AstraZeneca Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 AstraZeneca Brand Drugs Main Business and Markets Served
-
11.16.4 AstraZeneca Brand Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Bayer
-
11.17.1 Bayer Company Details
-
11.17.2 Bayer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Bayer Brand Drugs Main Business and Markets Served
-
11.17.4 Bayer Brand Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Amgen
-
11.18.1 Amgen Company Details
-
11.18.2 Amgen Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Amgen Brand Drugs Main Business and Markets Served
-
11.18.4 Amgen Brand Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Takeda
-
11.19.1 Takeda Company Details
-
11.19.2 Takeda Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Takeda Brand Drugs Main Business and Markets Served
-
11.19.4 Takeda Brand Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 GlaxoSmithKline (GSK)
-
11.20.1 GlaxoSmithKline (GSK) Company Details
-
11.20.2 GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 GlaxoSmithKline (GSK) Brand Drugs Main Business and Markets Served
-
11.20.4 GlaxoSmithKline (GSK) Brand Drugs Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Brand Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Brand Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Chemistry Medicine Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Brand Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Brand Drugs Market Analysis and Outlook to 2028
-
13.1 Global Brand Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Brand Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Brand Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Brand Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Brand Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Brand Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Brand Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Brand Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Brand Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Brand Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Brand Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Brand Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Brand Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Brand Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Brand Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Brand Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Brand Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Brand Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Brand Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Brand Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Brand Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Brand Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Brand Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Brand Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Brand Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Brand Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Brand Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Brand Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Brand Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Brand Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Brand Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Brand Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Brand Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Brand Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Brand Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Brand Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Brand Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Brand Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Brand Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Brand Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Brand Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Brand Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Brand Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Brand Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Brand Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Brand Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Brand Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Brand Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Brand Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Brand Drugs
-
Figure of Brand Drugs Picture
-
Table Global Brand Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Brand Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Chemistry Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Brand Drugs Consumption by Country (2017-2022)
-
Table North America Brand Drugs Consumption by Country (2017-2022)
-
Figure United States Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Brand Drugs Consumption by Country (2017-2022)
-
Figure Germany Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Brand Drugs Consumption by Country (2017-2022)
-
Figure China Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Brand Drugs Consumption by Country (2017-2022)
-
Figure Brazil Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Brand Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Brand Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Brand Drugs Consumption by Country (2017-2022)
-
Figure Australia Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Brand Drugs Consumption and Growth Rate (2017-2022)
-
Table Merck & Co (MSD) Company Details
-
Table Merck & Co (MSD) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co (MSD) Brand Drugs Main Business and Markets Served
-
Table Merck & Co (MSD) Brand Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Brand Drugs Main Business and Markets Served
-
Table Sanofi Brand Drugs Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Brand Drugs Main Business and Markets Served
-
Table Allergan Brand Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Brand Drugs Main Business and Markets Served
-
Table Pfizer Brand Drugs Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Brand Drugs Main Business and Markets Served
-
Table Gilead Sciences Brand Drugs Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Brand Drugs Main Business and Markets Served
-
Table Eli Lilly Brand Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Brand Drugs Main Business and Markets Served
-
Table Johnson & Johnson Brand Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Brand Drugs Main Business and Markets Served
-
Table Novartis Brand Drugs Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Brand Drugs Main Business and Markets Served
-
Table Bristol-Myers Squibb Brand Drugs Product Portfolio
-
Table Shire Company Details
-
Table Shire Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Brand Drugs Main Business and Markets Served
-
Table Shire Brand Drugs Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Brand Drugs Main Business and Markets Served
-
Table Novo Nordisk Brand Drugs Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Brand Drugs Main Business and Markets Served
-
Table AbbVie Brand Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Brand Drugs Main Business and Markets Served
-
Table Roche Brand Drugs Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Brand Drugs Main Business and Markets Served
-
Table Boehringer Ingelheim Brand Drugs Product Portfolio
-
Table Teva Company Details
-
Table Teva Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Brand Drugs Main Business and Markets Served
-
Table Teva Brand Drugs Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Brand Drugs Main Business and Markets Served
-
Table AstraZeneca Brand Drugs Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Brand Drugs Main Business and Markets Served
-
Table Bayer Brand Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Brand Drugs Main Business and Markets Served
-
Table Amgen Brand Drugs Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Brand Drugs Main Business and Markets Served
-
Table Takeda Brand Drugs Product Portfolio
-
Table GlaxoSmithKline (GSK) Company Details
-
Table GlaxoSmithKline (GSK) Brand Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline (GSK) Brand Drugs Main Business and Markets Served
-
Table GlaxoSmithKline (GSK) Brand Drugs Product Portfolio
-
Figure Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemistry Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brand Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Brand Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
